Literature DB >> 8781662

The effect of TNF-alpha and IL-6 on the permeability of the rat blood-retinal barrier in vivo.

S D Bamforth1, S Lightman, J Greenwood.   

Abstract

The blood-retinal barrier (BRB), which is formed by the retinal vascular endothelium and the retinal pigment epithelium, is responsible for controlling the passage of cells and molecules into the neuroretina. During ocular inflammatory diseases, however, this selective control is altered due to changes in BRB function such as increased permeability and leucocyte recruitment. The causative factors leading to barrier breakdown are not entirely understood although cytokines have recently been implicated. We have investigated the effect of the cytokines tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) upon the integrity of the rat BRB. Lewis rats received a dose of each cytokine by intravitreal injection and the permeability of the BRB was assessed using the smaller molecular weight vascular tracer 14C mannitol. A significant opening of the barrier to mannitol was detected following an intravitreal injection of 2 x 10(4) U of TNF-alpha which persisted from day 1 to day 5 post-injection (PI). The permeability of the BRB returned to normal values by day 7 PI. Only occasional mononuclear inflammatory cells were seen in the retina and vitreous of the TNF-alpha-treated eyes although they remained in evidence up to day 5 PI. In the TNF-alpha-infected eye there was immunohistological evidence of activation of tissue-resident cells, particularly in the inner plexiform layer. Of particular interest was the observation that the BRB of the non-injected contralateral eye also exhibited increased permeability over a similar time-course but without any evidence of cellular infiltration or activation of tissue-resident cells. Unlike TNF-alpha, the administration of 1 x 10(3) U of IL-6 into the vitreous caused no measurable increase in BRB permeability despite inducing a small infiltration of inflammatory cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8781662     DOI: 10.1007/s004010050476

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  16 in total

Review 1.  Macular oedema: the role of soluble mediators.

Authors:  D Kent; S A Vinores; P A Campochiaro
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

2.  Bluetongue virus and double-stranded RNA increase human vascular permeability: role of p38 MAPK.

Authors:  Eddie T Chiang; Dixie-Ann Persaud-Sawin; Sandhya Kulkarni; Joe G N Garcia; Farhad Imani
Journal:  J Clin Immunol       Date:  2006-07       Impact factor: 8.317

3.  Thrombin regulates chemokine induction during human retinal pigment epithelial cell/monocyte interaction.

Authors:  A Yoshida; S G Elner; Z M Bian; S L Kunkel; N W Lukacs; V M Elner
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

4.  Astrocytic alterations in interleukin-6/Soluble interleukin-6 receptor alpha double-transgenic mice.

Authors:  A G Brunello; J Weissenberger; A Kappeler; C Vallan; M Peters; S Rose-John; J Weis
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

5.  Interleukin-1 beta-induced disruption of the retinal vascular barrier of the central nervous system is mediated through leukocyte recruitment and histamine.

Authors:  S D Bamforth; S L Lightman; J Greenwood
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

6.  Leukocyte diapedesis in vivo induces transient loss of tight junction protein at the blood-retina barrier.

Authors:  Heping Xu; Rosemary Dawson; Isabel J Crane; Janet Liversidge
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-07       Impact factor: 4.799

Review 7.  The multifactorial nature of retinal vascular disease.

Authors:  Mark E Kleinman; Judit Z Baffi; Jayakrishna Ambati
Journal:  Ophthalmologica       Date:  2010-08-18       Impact factor: 3.250

8.  Relationship between systemic cytokines and complement factor H Y402H polymorphism in patients with dry age-related macular degeneration.

Authors:  Sijia Cao; Ashley Ko; Marita Partanen; Kaivon Pakzad-Vaezi; Andrew B Merkur; David A Albiani; Andrew W Kirker; Aikun Wang; Jing Z Cui; Farzin Forooghian; Joanne A Matsubara
Journal:  Am J Ophthalmol       Date:  2013-09-29       Impact factor: 5.258

9.  Systemic administration of HMG-CoA reductase inhibitor protects the blood-retinal barrier and ameliorates retinal inflammation in type 2 diabetes.

Authors:  Jingming Li; Joshua J Wang; Danyang Chen; Robert Mott; Qiang Yu; Jian-xing Ma; Sarah X Zhang
Journal:  Exp Eye Res       Date:  2009-02-28       Impact factor: 3.467

Review 10.  Microglia are crucial regulators of neuro-immunity during central nervous system tuberculosis.

Authors:  Jonathan Paul Spanos; Nai-Jen Hsu; Muazzam Jacobs
Journal:  Front Cell Neurosci       Date:  2015-05-18       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.